Abstract
Abstract
Introduction:
Thoracic sympathectomy remains an effective method for treatment of palmar hyperhidrosis refractory to other conservative forms of management. The procedure has become more acceptable following the introduction of the minimally invasive technique using video-assisted thoracic surgery (VATS). More recently, single-port VATS has gained popularity as an alternative approach to performing sympathectomy. We report on our experience and early results of single-port bilateral VATS sympathectomy using the Vasoview® (Maquet Inc., Rastatt, Germany) device at our institute.
Subjects and Methods:
All patients who underwent VATS sympathectomy for primary palmar hyperhidrosis between June 2011 and March 2012 were recruited into this prospective study. Patients' demographics and intraoperative and postoperative outcomes were collected. Effectiveness of the procedure, postoperative pain, duration of hospital stay, and complications were also measured.
Results:
Sixteen patients underwent Vasoview bilateral VATS sympathectomy for severe palmar hyperhidrosis. Mean age was 23.8 years (range, 17–36 years), and mean operative time to complete the bilateral procedure was 56 minutes (range, 42–81 minutes). The procedure was successfully completed in all patients without the need to enlarge the incision or convert. Postoperatively, there was no mortality and no residual palmar hyperhidrosis. Mean postoperative stay was 0.9 days (range, 0.7–1.9 days). The mean visual analog pain score at discharge was 1.8 (range, 1.2–3.4).
Conclusions:
Single-port Vasoview sympathectomy for treatment of severe palmar hyperhidrosis is technically feasible and safe with satisfactory immediate and early results. Intermediate and long-term follow-up is required to monitor recurrence or late complications. Future studies are warranted to compare Vasoview single-port and other minimal invasive VATS approaches.
Introduction
S
Subjects and Methods
Between June 2011 and March 2012, 10 females and 6 males with a mean age of 23.8 (range, 17–36 years) underwent bilateral single-port sympathicotomy with the Vasoview device for severe palmar hyperhidrosis. Before the patient was accepted for surgery, secondary causes of palmar hyperhidrosis were excluded, as well as all patients having a pulse rate greater than 55 beats per minute at rest. 5 General anesthesia was administered, with a double-lumen endobronchial tube in all cases. A finger temperature probe was used to detect any rise in peripheral cutaneous temperature following sympathicotomy. Our technique was previously described 4 (Fig. 1). A 1-cm left chest wall axillary incision is made posterior to the lateral border of the pectoralis major muscle, in the third intercostal space. At the discretion of the surgeon, the Vasoview 7XS bipolar diathermy scissors or the Hemopro or Hemopro 2 dissecting grasper was used to achieve sympathicotomy with transection of the sympathetic chain at the top of the third rib and at the top of the fourth rib. The nerve segment in between, as well as their lateral aspects along the ribs containing the fibers of Kuntz, was subsequently ablated. Following the bilateral procedure, the patients were extubated and then discharged later in the day.

Operating room photograph illustrating the patient's position, equipment set-up, and surgical access for Vasoview sympathectomy.
Results
The Vasoview 7XS was used in 6 patients, the Hemopro with a dissecting grasper using Starion Instruments (Sunnyvale, CA) technology was used in 6 patients, and the Hemopro 2 with the additional feature of an overheating temperature sensor was used in 4 patients. Mean operative time to complete the bilateral procedure was 56 minutes (range, 42–81 minutes). The operative duration for all the energy devices decreased with increasing experience. The procedure was successfully completed in all patients, without the need to extend the incision or convert. No residual palmar hyperhidrosis was detected postoperatively. Mean postoperative hospital stay was 0.9 days (range, 0.7–1.9 days). The delayed discharge in 1 patient was due to nausea from the anesthesia. There were no postoperative complications such as pneumothorax, hemothorax, infections, or Horner's syndrome. The mean visual analogue pain score at discharge was 1.8 (range, 1.2–3.4). At a mean postoperative follow-up of 15 months (range, 12–20 months), mild compensatory hyperhidrosis (truncal predominance) was seen in 2 (12.5%) patients, and no palmar hyperhidrosis recurrence has been detected thus far.
Discussion
In the past two decades, VATS sympathectomy has matured from a three-port technique using 10-mm instruments to the modern needlescopic 3-mm instrument approach using two to three ports. More recently, single-port thoracic sympathectomy has been reported, although access through one incision often results in difficulties of instrument crowding and fencing. 6
The VasoView device was designed for and is widely used for endoscopic vein harvesting to retrieve conduits for procedures such as coronary artery bypass grafting surgery. The device incorporates a 7-mm high-resolution thoracoscope, CO2 insufflation channel, retractable C-arm with in-built lens cleaner, and parallel working channel for dissecting diathermy scissors or other energy devices like Hemopro graspers. Single-port VasoView sympathectomy was first reported by Bouma et al. 3 in 2011. They successfully performed bilateral sympathectomy on 3 patients using the VasoView 7XS device with the bipolar diathermy scissors. 3 Since then, more modern versions of the device, the Vasoview Hemopro and Hemopro 2, have been introduced, which use a dissecting grasper with Starion technology that has a gradated thermal tip and pressure to cut and coagulate without electric current passing through tissues. 4 Consequently, collateral thermal tissue damage is minimized, 7 which in the context of sympathectomy may potentially reduce the risk of inadvertent superior sympathetic chain injury and associated complications including Horner's syndrome. In our experience, all three versions of the VasoView device are user friendly for sympathicotomy, with no difference in complication or operating duration among the systems. Although the 7XS scissors may achieve nerve division more rapidly, the Hemopro was better at ablating the nerve segment and grasping the nerve for sympathectomy.
Although we experienced no intraoperative difficulties, unlike three-port VATS, the ability of single-port VATS and indeed this device in dealing with pleural adhesions or bleeding from chest wall vessels may be limited. However, in 1 patient we did encounter apical vascular adhesion bands that were successfully divided by the Hemopro device with good hemostatic effect. This hemostatic ability is perhaps expected given that the Vasoview device was designed to divide and coagulate branches of the saphenous vein. The current series is relatively small, and a more prolonged and detailed follow-up is required to truly evaluate the benefits and long-term results of this approach. In particular, randomized trials are required to compare the single-port Vasoview technique with the two-port or three-port 3-mm VATS sympathectomy approaches for postoperative pain, cosmesis, and patient satisfaction, as well as the cost-effectiveness of using such disposable devices. To conclude, our initial results show that single-port bilateral sympathectomy with Vasoview incorporating the 7XS, Hemopro, or Hemopro 2 dissecting system can be safely and effectively performed with satisfactory outcomes. Further studies will better define the role of Vasoview devices in VATS thoracic sympathectomy.
Disclosure Statement
No competing financial interests exist.
